We are live on ! Find out more
CCM

Cantillon Capital Management Portfolio holdings

AUM $665M
1-Year Est. Return 25.91%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+25.91%
3 Year Est. Return
+105.25%
5 Year Est. Return
+112.09%
10 Year Est. Return
+580.93%
AUM
$8.89B
AUM Growth
-$397M
Cap. Flow
-$666M
Cap. Flow %
-7.49%
Top 10 Hldgs %
46.03%
Holding
35
New
1
Increased
3
Reduced
30
Closed
1

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$123M
2
INTC icon
Intel
INTC
+$83.2M
3
EFX icon
Equifax
EFX
+$71.4M
4
IBKR icon
Interactive Brokers
IBKR
+$8.6M

Sector Composition

Rank Sector Weight
1 Financials 29.06%
2 Technology 23.49%
3 Communication Services 13.47%
4 Industrials 11.62%
5 Healthcare 11.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAST icon
26
Fastenal
FAST
$58.3B
$174M 1.96%
11,994,940
-809,884
-6% -$11.5M
CMPR icon
27
Cimpress
CMPR
$2.34B
$163M 1.83%
1,192,602
-83,128
-7% -$12M
SSNC icon
28
SS&C Technologies
SSNC
$18.7B
$148M 1.66%
2,598,071
-165,475
-6% -$9.18M
IBKR icon
29
Interactive Brokers
IBKR
$38.8B
$145M 1.63%
10,461,300
+567,152
+6% +$8.6M
CACC icon
30
Credit Acceptance
CACC
$6.03B
$133M 1.5%
303,625
-20,735
-6% -$8.7M
TMO icon
31
Thermo Fisher Scientific
TMO
$214B
$131M 1.47%
+535,849
New +$123M
PRI icon
32
Primerica
PRI
$10.2B
$113M 1.27%
937,310
-68,731
-7% -$7.97M
AWI icon
33
Armstrong World Industries
AWI
$7.78B
$74.5M 0.84%
1,070,589
-80,079
-7% -$5.52M
TMX
34
DELISTED
Terminix Global Holdings, Inc.
TMX
$69.5M 0.78%
1,673,935
-7,092,506
-81% -$284M
AGN
35
DELISTED
Allergan plc
AGN
-204,467
Closed -$34.1M

Similar funds

Cantillon Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Cantillon Capital Management held 35 positions worth $8.89B, down 4.3% from $9.29B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cantillon Capital Management withdrew a net $666M in Q3 2018, closing 1 position and reducing 30 holdings. Its most notable exit was Allergan plc, an estimated $34.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Cantillon Capital Management opened a new position in Thermo Fisher Scientific worth $131M.

  • Cantillon Capital Management's largest Q3 2018 buy was Thermo Fisher Scientific: 535,849 shares worth $131M.
  • Cantillon Capital Management added most to Intel in Q3 2018, an estimated $83.2M increase.
  • Cantillon Capital Management's biggest Q3 2018 reduction was Terminix Global Holdings, Inc., cutting an estimated $284M.
  • Cantillon Capital Management fully exited Allergan plc in Q3 2018, selling an estimated $34.1M.
  • Cantillon Capital Management's ten largest holdings make up 46% of its $8.89B portfolio in Q3 2018.
  • Cantillon Capital Management opened 1 new position and closed 1 in Q3 2018.
  • Cantillon Capital Management's portfolio value fell 4.3% quarter-over-quarter to $8.89B.

Based on Cantillon Capital Management's 13F filing for Q3 2018, filed 9 Nov 2018.